Anette Müllertz is professor in the Department of Pharmacy, University of Copenhagen, Denmark. She is head of Bioneer:FARMA, funded by the Danish Ministry of Science and Technology to establish research-based scientific services within the area of Drug Development. After receiving her PhD degree in lipid nutrition at the Technical University of Denmark, she worked for Novo Nordisk A/S, on the development of e.g. structured lipids, digestive lipases, and digestion models. Now, at the University of Copenhagen, she is head of the Rational Oral Drug Delivery Research Group, which focuses on developing predictive biopharmaceutical tools for oral drug development and lipid-based formulations. She has contributed to over 130 publications in international peer-reviewed journals and 10 book chapters. She is also a winner of the AAPS Lipid-Based Drug Delivery Award. Yvonne Perrie is Professor of Drug Delivery within the Strathclyde Institute of Pharmacy and Biomedical Sciences at University of Strathclyde, Scotland. She graduated with First-Class Honours in Pharmacy from Strathclyde University and earned a PhD from the University of London under the supervision of Prof. Gregoriadis. Prof. Perrie’s research is multi-disciplinary and focuses on the development of drug carrier systems for the delivery of drugs and vaccines to enhance patient care globally. Prof. Perrie is a Director-at-large for the Controlled Release Society. She is Editor-in-Chief of both the Journal of Liposome Research and Pharmaceutics; she is also Associate Editor for the Journal of Drug Targeting and the Journal of Pharmacy and Pharmacology. Thomas Rades is the Research Chair in Pharmaceutical Design and Drug Delivery at the Department of Pharmacy, University of Copenhagen, Denmark. Dr. Rades obtained his PhD from the Technical University of Braunschweig, Germany and has developed an international reputation forhis research on solid drugs and dosage forms as well as in vaccine delivery. Research in both areas aim to improve drug therapy through appropriate formulation and the characterization of medicines; another objective is to increase am understanding of the physico-chemical properties of drugs and medicines. Dr. Rades has published more than 325 papers in international peer reviewed journals. He is an editor of the Journal of Pharmaceutical Sciences, the European Journal of Pharmaceutics, and Biopharmaceutics. Dr. Rades holds an honorary doctorate from Åbo Akademie University (Finland); he is also an Eminent Fellow of the Academy of Pharmaceutical Sciences (UK), a Fellow of the New Zealand Institute of Chemistry, and a member of the College of Fellows of the Controlled Release Society.
